Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2019-000171-16Phase 4Unknown
Phase 4, randomised trial of propofol, desflurane, isoflurane and sevoflurane in ischemia-reperfusion injury (IRI) and coronary arteriosclerosis (2 arms), sponsored by King's College Hospital. Primary endpoints: Feasibility of study protocol and Follow-up rate at 30 days. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2019-000171-16.